Proposal benchmarking on pap and paracetamol production in china

Benchmarking on
PAP and Paracetamol
Production in China
Guangzhou CCM Information Science & Technology Co., Ltd.
Guangzhou, P. R. China
Researched & Prepared by:
Proposal
The Third Edition
November 2010

CCM Data & Primary Intelligence
Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com
Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
Benchmarking on PAP and Paracetamol Production
in China
Proposal – The Third Edition
November 2010
1. Introduction
Paracetamol, short for para-acetamino phenol, plays an important role in NSAIDs, namely
non-steroidal anti-inflammatory drugs. And para-amino phenol (PAP) is the key raw material for
paracetamol production.
In 2008, CCM has carried out benchmarking on PAP and paracetamol production in China (the second
edition). And after two years, with more attention on environment from government and technological
improvement in production, the PAP and paracetamol production has changed much in China.
In this report, CCM will survey Bengbu Bayi (the only PAP producer adopting catalytic hydrogenation of
p-nitrophenol technology in China), Taixing Yangtze, Liaoning Shixing (top two PAP producers in terms
of capacity adopting iron reduction of p-nitrochlorobenzene technology) to replace PAP producers in
last edition (Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua), and add Zhejiang Kangle
(the third largest paracetamol producers in China) in paracetamol benchmarking.
In addition, the future of paracetamol, PAP and its upstream industry and the government's support in
China will be revealed in this report. CCM will also find out the alternative replacement product for
paracetamol, i.e. and the threat product for APAP in the future.
What are the aims of the report?
- Brief introduction to PAP and paracetamol industry in China
- Governmental policies on PAP & paracetamol industry in China
- Introduction to processes for PAP and paracetamol production
- Most popular methods of PAP and paracetamol in China
- Financial analysis of target PAP and paracetamol producers
- Production cost analysis on target PAP and paracetamol producers
- The future of paracetamol, PAP and its upstream industry
- The alternative replacement product for paracetamol, i.e. and the threat product for paracetamol in
the future

CCM Data & Primary Intelligence
Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
What will CCM summit to clients?
- Independent and authoritative research report in Word-format with around 100-150 pages
- Over 50 primary tables & 15 figures from a new benchmarking research survey to ensure
unrivalled details and most up-to-date info about the market;
- Benchmarking data of all target producers in Excel-format
2. Scopes of investigation
The research of benchmarking on PAP and paracetamol production mainly focuses on China,
covering:
Participants:
- Producers
- Raw materials suppliers
- Technology researchers
PAP and paracetamol market
- Production
- Raw material supply
- Technologies
- Forecast

CCMData & Primary Intelligence
Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
3. Main content
Benchmarking on PAP and Paracetamol Production in China
Part Content Remark
(compared with
last edition)
Executive summary
Introduction and methodologies
I Review of PAP & paracetamol industry
I-1 Brief introduction to paracetamol industry in China
I-2 Brief introduction to PAP industry in China
Update
I-3 Governmental policies on PAP & paracetamol industry in China Newly added
II Brief introduction to various technologies of PAP and paracetamol in
China
II-1 Introduction to processes for PAP production
II-1.1 Industrialized technologies of PAP
- Iron reduction of p-nitrophenol
- Catalytic hydrogenation of p-nitrophenol
- Catalytic hydrogenation of nitrobenzene
II-1.2 Technologies under research
- Electrolytic reduction of nitrobenzene
- Other findings
II-1.3 Comparison among the above four technologies
II-2 Introduction to processes for paracetamol production
II-2.1 One-step method
II-2.2 Two-step method
Update,
concerning on
the latest
research in
China
III Detailed introduction to currently most popular methods of PAP and
paracetamol
III-1 Technology for PAP
III-1.1 Description of production process and theoretical model of raw materials by
iron reduction technology
III-1.2 Description of production process and theoretical model of raw materials by
nitrobenzene catalytic hydrogenation technology
III-2 Technology for paracetamol
III-2.1 Brief description of production process
III-2.2 Flow chart of paracetamol production
III-2.3 Theoretical model of raw materials
Update
IV Estimation on cost and profit of PAP and paracetamol
IV-1 In PAP enterprises
IV-1.1 Taixing Yangtze (adopting PNCB technology)
- Basic situation in Taixing Yangtze
- Financial analysis of Taixing Yangtze in 2009
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
Newly add

Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
- Estimation on total production cost
- Estimation on profit
IV-1.2 Liaoning Shixing (adopting PNCB technology)
- Basic situation in Liaoning Shixing
- Financial analysis of Liaoning Shixing in 2009
Newly add
Liaoning
Shixing and
Liaoning
Tianbao are the
only two PAP
producers in
Huludao.
IV-1.3 Bengbu Bayi (adopting catalytic hydrogenation of p-nitrophenol technology)
- Basic situation in Bengbu Bayi
- Financial analysis of Bengbu Bayi in 2009
Newly add
IV-1.4 Comparison among above three producers Update
IV-2 In paracetamol enterprises
IV-2.1 Lu’an Pharm
- Basic situation in Lu’an Pharm
- Financial analysis of Lu’an Pharm in 2009
Update
IV-2.2 Hebei Jiheng
- Basic situation in Hebei Jiheng
- Actual flowchart in Hebei Jiheng
- Financial analysis of Hebei Jiheng in 2009
Update
IV-2.3 Zhejiang Kangle
- Basic situation in Zhejiang Kangle
- Financial analysis of Zhejiang Kangle in 2009
Newly add

Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
IV-2.4 Comparison among above three producers Update
IV-2.5 Nanjing Petrochemical
- Basic situation in Nanjing Petrochemical
- Process on its paracetamol project
Newly add
Nanjing
Petrochemical
doesn’t
produce PAP,
while it has a
paracetamol
project, whose
detailed
information we
will need to
confirm in this
report.
V Forecast on PAP & paracetamol industry in China
V-1 Forecast on market (Paracetamol & PAP and its upstream industry)
V-2 Forecast on technology
Update
V-3 Alternative replacement products for paracetamol in the future Newly add
VI Site visit reports Update
Difficulties and solutions
Item Difficulty Solution
Financial analysis Most producers are not listed companies, and
their financial data are not transparent.
Meanwhile, since these enterprises also
produce other products, financial data can’t
completely reflect the PAP or paracetamol
production.
Financial data will be purchased from
third party, and then given the analysis,
which is only a reference to benchmark
PAP or paracetamol production.
PAP producer According to our last visit experience, It is
difficult to site visit Liaoning Shixing and
Bengbu Bayi, especially for Bengbu Bayi, the
only PAP producer adopting catalytic
hydrogenation of p-nitrophenol technology in
China, who keeps their technology confidential.
CCM will endeavor to conduct the site
visit on these two producers. Or Lu’an
Pharm and Changshu Fengyi will be
alternatives for PAP producers. (except
Jiangsu Zhongming and Liaoning
Tianbao, these two companies rank
after above target producers in terms of
capacity)
Paracetamol producer We can not be sure to site visit all these three
producers to get the first-hand data.
Tianjin Bofa and Bayi Pharm will be
alternatives for paracetamol producer
survey. (these two companies rank after
above target producers in terms of
capacity)

Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
4. Methodology and sources
Periodicals, magazines,
journals, Internet, CCM
database, other public
media or third party
database
Desk research
Producers, raw materials
suppliers, associations,
industrial experts, etc.
Telephone
interview
Financial data, journals,
etc.
Financial analysis
Quantitative &
qualitative analysis,
discussion,
forecast,etc.
Report generationSite visit
ValoTracer
StepData sources
Data to be collected and compiled by CCM will be sourced from:
- CCM database (mainly based on ValoTracer)
- Published articles from Chinese and foreign periodicals, magazines, journals, third-party database
- Telephone interviews with Chinese producers, raw materials suppliers
- Site visits on producers
- Comments from industrial experts
- Information from the Internet
- Other public media
The research for the report will consist of five stages:
Stage 1 Desk research
The sources of desk research are various, including Chinese and foreign published magazines,
journals, association seminars as well as information from the Internet. A lot of work will go into
compilation and analysis of the obtained information.
Stage 2 Telephone interviews
CCM will carry out extensive telephone interviews in order to survey the actual situation in PAP and
paracetamol production.
Interviewees will cover:
- Key producers

Tel: +86-20-3761 6606 Fax: +86-20-3761 6968
- Raw material suppliers
- Some associations
- Researchers and research institutes
Stage 3 Financial analysis
Financial data in 2009 will be gotten from third-party database suppliers or annual report about listed
companies. And then financial analysis will be necessary to further understand financial situation about
target producers. Finally, the advantages and disadvantages will be revealed after comparison among
the target producers who manufacture the same product.
Of course, financial analysis is only a reference to benchmark PAP or paracetamol production since
these enterprises not only produce PAP or paracetamol, but also other products.
Stage 4 Site visits
CCM will carry out site visits and face-to-face interviews with all target producers which will be identified
through telephone interviews.
The site visits will be presented in the finial report.
Stage 5 Report generation
Logical analysis and scientific ratiocination will be conducted to generate the report. All the data and
findings obtained in the above four stages will be presented in the report clearly.
5. Submission time
CCM schedules to finish this report in 2 months after you order.

Copyright © Guangzhou CCM Information Science & Technology Co., Ltd.
Any publication, distribution or copying of the content is prohibited.
Address: 17th Floor, Huihua Commercial & Trade Building, No.80 Xianlie Zhong Road
Guangzhou, 510070, P. R. China
Tel: +86-20-37616606
Fax: +86-20-37616968
E-mail: econtact@cnchemicals.com
Website: www.cnchemicals.com
Related products:
Benchmarking on PAP and Paracetamol
Production in China (Second edition)
The p-Amino Phenol (PAP) Industry in China
(Fourth edition)
The Paracetamol Industry in China (Fifth
edition)

Proposal benchmarking on pap and paracetamol production in china

Recomendados

Recomendados

Más contenido relacionado

Más de CCM Intelligence

Más de CCM Intelligence (20)

Último

Último (20)

Proposal benchmarking on pap and paracetamol production in china